Provectus Biopharmaceuticals (PVCT) Enterprise Value (2010 - 2026)
Provectus Biopharmaceuticals (PVCT) recorded Enterprise Value of $28.25 million in Q2 2026, down 14.9% from $33.2 million a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Enterprise Value (2010 - 2026) Analysis & Trends
On a TTM basis, Provectus Biopharmaceuticals' Enterprise Value came in at $27.51 million as of Jun 30, 2026, down 13.0% year-over-year; for FY2025, it was $24.96 million, down 50.0% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $49.93 million in FY2024 (+22.0%), $40.93 million in FY2023 (-8.5%), $44.71 million in FY2022 (+150.3%) and $17.87 million in FY2021 (-25.0%).
- Quarterly Enterprise Value has ranged from $17.87 million in Q4 2021 to $74.75 million in Q1 2024 over the past five years.
- On a year-over-year basis, Enterprise Value rose in two of the last seven quarters, with an average decline of 17.2%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 160.4% in Q1 2023, against a decline of 50.0% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.89 Bn | 1,138.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 648.35 Bn | 568.21 Bn | 17.30 Bn |
| 3 | AbbVie | 504.24 Bn | 477.35 Bn | 12.70 Bn |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.28 Bn | 267.27 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn |
| 7 | Amgen | 242.76 Bn | 198.16 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn |
| 9 | Pfizer | 172.99 Bn | 119.64 Bn | 10.94 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.25 Mn |
| Dec 31, 2025 | 24.96 Mn |
| Sep 30, 2025 | 37.74 Mn |
| Jun 30, 2025 | 33.20 Mn |
| Mar 31, 2025 | 41.59 Mn |
| Dec 31, 2024 | 49.93 Mn |
| Sep 30, 2024 | 41.41 Mn |
| Jun 30, 2024 | 54.00 Mn |
| Mar 31, 2024 | 74.75 Mn |
| Dec 31, 2023 | 40.93 Mn |
| Sep 30, 2023 | 36.35 Mn |
| Jun 30, 2023 | 44.79 Mn |
| Mar 31, 2023 | 69.99 Mn |
| Dec 31, 2022 | 44.71 Mn |
| Sep 30, 2022 | 19.27 Mn |
| Jun 30, 2022 | 23.14 Mn |
| Mar 31, 2022 | 26.88 Mn |
| Dec 31, 2021 | 17.87 Mn |
| Sep 30, 2021 | 24.91 Mn |
| Jun 30, 2021 | 28.23 Mn |
API Access
Provectus Biopharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();